faculty photo

Kevin G. Lynch

Associate Professor of Biostatistics in Psychiatry at the Hospital of the University of Pennsylvania and the Children's Hospital of Philadelphia
Associate Scholar, Center for Clinical Epidemiology and Biostatistics (CCEB), University of Pennsylvania School of Medicine
Director, Biostatistics and Informatics Core, Center for Studies on Addictions, Dept. of Psychiatry, University of Pennsylvania, Philadelphia, PA
Department: Psychiatry
Graduate Group Affiliations

Contact information
3535 Market Street, #5099
Philadelphia, PA 19104
Office: 215-746-7707
Fax: 215-746-2988
B.Sc. ((Mathematics))
University College, Galway, Ireland , 1988.
M.Sc. ( (Mathematics and Statistics))
University College, Galway, Ireland , 1989.
M.A. ((Statistics))
Yale University , 1990.
Ph.D ((Statistics))
Yale University , 1997.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise


Selected Publications

Morgenstern J, Kuerbis A, Shao S, Treloar Padovano H, Vadhan NP and Lynch KG: An Efficacy Trial of Adaptive Interventions for Problem Drinkers. Journal of Substance Abuse Treatment 123: 108264, 2021.

Cenkner DP, Asnaani A, DiChiara C, Harb GC, Lynch KG, Greene J, and Scott JC: Neurocognitive Predictors of Treatment Outcomes in Cognitive Processing Therapy for Post-traumatic Stress Disorder: Study Protocol. Frontiers in Psychiatry 12: 625669, 2021.

Kranzler HR, Lynch KG, Crist RC, Hartwell E, Le Moigne A, Laffont CM, and Andorn AC: A Delta-Opioid Receptor Gene Polymorphism Moderates the Therapeutic Response to Extended-Release Buprenorphine in Opioid Use Disorder. International Journal of Neuropsychopharmacology 24(2): 89-96, 2021.

Wetherill RR, Spilka N, Jagannathan K, Morris P, Romer D, Pond T, Lynch KG, and Kranzler HR: Topiramate effects on neural responses to alcohol cues and heavy drinking among treatment-seeking individuals with alcohol use disorder. Neuropsychopharmacology 46: 1414–1420, 2021.

Oslin DO, Chapman S, Duvall S, Gelernter J, Hill K, Icardi M, Ingram E, Kilbourne A, Kranzler H, Lehmann L, Lynch K, Meyer L, Muralidhar S, Przygodzki R, Pyne J, Schichman S, Schneweis J, Shih M-C, Stone A, Tenhula W, Thase ME, Wray LO, and the PRIME Care site investigators: Study Design and Implementation of the PRecision medicine In MEntal health Care (PRIME Care) Trial. Contemporary Clinical trials 101: 106247, 2021.

Ramsey C, Lynch KG, Thase ME, Gelernter J, Kranzler HR, Pyne JM, Shih M-C, Stone A and Oslin DW: Prevalence of predicted gene-drug interactions for antidepressants in the treatment of major depressive disorder in the Precision Medicine in Mental Health Care Study. Journal of Affective Disorders 282: 1272-1277, 2021.

Woody GE, Poole S, Yu E, Carroll J, Lynch KG: Extended Release Injectable Naltrexone Before vs. After Release: A Randomized Trial of Opioid Addicted Prisoners. Journal of Substance Abuse Treatment 127: 108355, 2021.

Harris RA, Mandell DS, Kampman KM, Bao Y, Campbell K, Cidav Z, Coviello DM, French R, Livesey C, Lowenstein M, Lynch KG, McKay JR, Oslin DW, Wolk CB, Bogner HR: Collaborative Care in the Treatment of Opioid Use Disorder and Mental Health Conditions in Primary Care: A Clinical Study Protocol. Contemporary Clinical trials 103: 106325, 2021.

Kranzler HR, Morris PE, Pond T, Crist R, Kampman KM, Hartwell E, and Lynch KG: Prospective Randomized Pharmacogenetic Study of Topiramate for Treating Alcohol Use Disorder. Neuropsychopharmacology 46: 1407-1413, 2021.

Brown L, Lynch KG, and Cheatle M: Pain catastrophizing as a predictor of suicidal ideation in chronic pain patients with an opiate prescription. Psychiatry Research 286: 112893, 2020.

back to top
Last updated: 07/16/2021
The Trustees of the University of Pennsylvania
Back to Top